Role of imaging in progressive-fibrosing interstitial lung diseases

Imaging techniques are an essential component of the diagnostic process for interstitial lung diseases (ILDs). Chest radiography is frequently the initial indicator of an ILD, and comparison of radiographs taken at different time points can show the rate of disease progression. However, radiography provides only limited specificity and sensitivity and is primarily used to rule out other diseases, such as left heart failure. High-resolution computed tomography (HRCT) is a more sensitive method and is considered central in the diagnosis of ILDs. Abnormalities observed on HRCT can help identify specific ILDs. HRCT also can be used to evaluate the patient's prognosis, while disease progression can be assessed through serial imaging. Other imaging techniques such as positron emission tomography-computed tomography and magnetic resonance imaging have been investigated, but they are not commonly used to assess patients with ILDs. Disease severity may potentially be estimated using quantitative methods, as well as visual analysis of images. For example, comprehensive assessment of disease staging and progression in patients with ILDs requires visual analysis of pulmonary features that can be performed in parallel with quantitative analysis of the extent of fibrosis. New approaches to image analysis, including the application of machine learning, are being developed. Imaging techniques, particularly HRCT, are the cornerstone for ILD diagnosis and new approaches to analysing HRCT images, including machine-learning technology, are being developed http://ow.ly/1R1e30mOqhn

[1]  Jonathan H. Chung,et al.  CT Findings, Radiologic-Pathologic Correlation, and Imaging Predictors of Survival for Patients With Interstitial Pneumonia With Autoimmune Features. , 2017, AJR. American journal of roentgenology.

[2]  H. Collard,et al.  The diagnosis of idiopathic pulmonary fibrosis: current and future approaches. , 2017, The Lancet. Respiratory medicine.

[3]  David A Lynch,et al.  High-resolution computed tomography in idiopathic pulmonary fibrosis: diagnosis and prognosis. , 2005, American journal of respiratory and critical care medicine.

[4]  Usual interstitial pneumonia pattern in chronic hypersensitivity pneumonitis , 2016 .

[5]  F. Salaffi,et al.  Computer-Aided Quantification of Interstitial Lung Disease from High Resolution Computed Tomography Images in Systemic Sclerosis: Correlation with Visual Reader-Based Score and Physiologic Tests , 2015, BioMed research international.

[6]  Jonathan H. Chung,et al.  CT scan findings of probable usual interstitial pneumonitis have a high predictive value for histologic usual interstitial pneumonitis. , 2015, Chest.

[7]  Takeshi Johkoh,et al.  American Thoracic Society Documents An Official ATS / ERS / JRS / ALAT Statement : Idiopathic Pulmonary Fibrosis : Evidence-based Guidelines for Diagnosis and Management , 2011 .

[8]  J. Behr.  Approach to the diagnosis of interstitial lung disease. , 2012, Clinics in chest medicine.

[9]  A. Nicholson,et al.  Short‐Term Pulmonary Function Trends Are Predictive of Mortality in Interstitial Lung Disease Associated With Systemic Sclerosis , 2017, Arthritis & rheumatology.

[10]  S. Mathai,et al.  Management of interstitial lung disease associated with connective tissue disease , 2016, BMJ : British Medical Journal.

[11]  Joyce S Lee,et al.  A Multidimensional Index and Staging System for Idiopathic Pulmonary Fibrosis , 2012, Annals of Internal Medicine.

[12]  Jonathan H. Chung,et al.  Characterisation of patients with interstitial pneumonia with autoimmune features , 2016, European Respiratory Journal.

[13]  Anand Devaraj,et al.  Connective tissue disease related fibrotic lung disease: high resolution computed tomographic and pulmonary function indices as prognostic determinants , 2013, Thorax.

[14]  M. Remy-Jardin,et al.  Predictors of lung function test severity and outcome in systemic sclerosis-associated interstitial lung disease , 2017, PloS one.

[15]  Anand Devaraj,et al.  Evaluating disease severity in idiopathic pulmonary fibrosis , 2017, European Respiratory Review.

[16]  Mark G. Jones,et al.  Idiopathic pulmonary fibrosis , 2017, The Lancet.

[17]  Evolving Early Lung Cancers Detected During Follow-Up of Idiopathic Interstitial Pneumonia: Serial CT Features. , 2015, AJR. American journal of roentgenology.

[18]  Sumit K. Shah,et al.  Quantitative texture-based assessment of one-year changes in fibrotic reticular patterns on HRCT in scleroderma lung disease treated with oral cyclophosphamide , 2011, European Radiology.

[19]  A Kahn,et al.  Interstitial lung disease. , 1982, The Journal of the Arkansas Medical Society.

[20]  A. Nicholson,et al.  HRCT diagnosis of diffuse parenchymal lung disease: inter-observer variation , 2004, Thorax.

[21]  F. Martinez,et al.  Clinical predictors of a diagnosis of idiopathic pulmonary fibrosis. , 2010, American journal of respiratory and critical care medicine.

[22]  K. Meyer,et al.  Diagnosis and management of interstitial lung disease , 2014, Translational Respiratory Medicine.

[23]  D. Lynch,et al.  Chronic hypersensitivity pneumonitis: differentiation from idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia by using thin-section CT. , 2008, Radiology.

[24]  U. Tateishi,et al.  Chronic Hypersensitivity Pneumonitis With a Usual Interstitial Pneumonia-Like Pattern: Correlation Between Histopathologic and Clinical Findings. , 2016, Chest.

[25]  A. Nicholson,et al.  Fibrotic idiopathic interstitial pneumonias: HRCT findings that predict mortality , 2011, European Radiology.

[26]  N. Müller,et al.  Fleischner Society: glossary of terms for thoracic imaging. , 2008, Radiology.

[27]  N. Goh,et al.  Extent of disease on high-resolution computed tomography lung is a predictor of decline and mortality in systemic sclerosis-related interstitial lung disease. , 2013, Rheumatology.

[28]  H. Collard,et al.  Design of the PF-ILD trial: a double-blind, randomised, placebo-controlled phase III trial of nintedanib in patients with progressive fibrosing interstitial lung disease , 2017, BMJ Open Respiratory Research.

[29]  David P. Naidich,et al.  Fibrosing interstitial lung disease. A practical high-resolution computed tomography-based approach to diagnosis and management and a review of the literature. , 2013, American journal of respiratory and critical care medicine.

[30]  H. Collard,et al.  Radiographic fibrosis score predicts survival in hypersensitivity pneumonitis. , 2013, Chest.

[31]  N. Müller,et al.  Computed tomography findings in pathological usual interstitial pneumonia: relationship to survival. , 2008, American journal of respiratory and critical care medicine.

[32]  T. Hartman,et al.  Automated quantification of radiological patterns predicts survival in idiopathic pulmonary fibrosis , 2013, European Respiratory Journal.

[33]  Lee Goldman,et al.  Goldman-Cecil Medicine , 2015 .

[34]  D. Lynch,et al.  Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper. , 2017, The Lancet. Respiratory medicine.

[35]  N. Bogot,et al.  Positron emission tomography in interstitial lung disease , 2007, Respirology.

[36]  D. Hansell,et al.  Chronic hypersensitivity pneumonitis: identification of key prognostic determinants using automated CT analysis , 2017, BMC Pulmonary Medicine.

[37]  H. Collard,et al.  The use of pretest probability increases the value of high-resolution CT in diagnosing usual interstitial pneumonia , 2017, Thorax.

[38]  D. Lynch,et al.  Idiopathic Pulmonary Fibrosis: The Association between the Adaptive Multiple Features Method and Fibrosis Outcomes , 2017, American journal of respiratory and critical care medicine.

[39]  T. Hartman,et al.  High-resolution CT findings of parenchymal fibrosis correlate with prognosis in hypersensitivity pneumonitis. , 2008, Chest.

[40]  D. Hansell,et al.  Chronic hypersensitivity pneumonitis: high resolution computed tomography patterns and pulmonary function indices as prognostic determinants , 2012, European Radiology.

[41]  M. Kitaichi,et al.  Chronic bird fancier’s lung: histopathological and clinical correlation. An application of the 2002 ATS/ERS consensus classification of the idiopathic interstitial pneumonias , 2005, Thorax.

[42]  Clinical Course and Changes in High-Resolution Computed Tomography Findings in Patients with Idiopathic Pulmonary Fibrosis without Honeycombing , 2016, PloS one.

[43]  K. Brown,et al.  What's in a name? That which we call IPF, by any other name would act the same , 2018, European Respiratory Journal.

[44]  T. Baba,et al.  The importance of subpleural fibrosis in the prognosis of patients with idiopathic interstitial pneumonias. , 2017, European journal of radiology.

[45]  T. Hartman,et al.  Diagnosis of interstitial lung diseases. , 2007, Mayo Clinic proceedings.

[46]  J. Gran,et al.  Predictive Value of Serial High‐Resolution Computed Tomography Analyses and Concurrent Lung Function Tests in Systemic Sclerosis , 2015, Arthritis & rheumatology.

[47]  Raúl San José Estépar,et al.  A comparison of visual and quantitative methods to identify interstitial lung abnormalities , 2015, BMC Pulmonary Medicine.

[48]  R. Elashoff,et al.  Relationship between quantitative radiographic assessments of interstitial lung disease and physiological and clinical features of systemic sclerosis , 2014, Annals of the rheumatic diseases.

[49]  K. Brown,et al.  Connective tissue disease-associated lung disease. , 2012, Immunology and allergy clinics of North America.

[50]  D. Lynch,et al.  Clinical and radiologic manifestations of hypersensitivity pneumonitis. , 2002, Journal of thoracic imaging.

[51]  Sang Min Lee,et al.  Quantitative assessment of change in regional disease patterns on serial HRCT of fibrotic interstitial pneumonia with texture-based automated quantification system , 2012, European Radiology.

[52]  Jong Sun Park,et al.  Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases , 2018, European Respiratory Review.

[53]  V. Cottin.  Idiopathic interstitial pneumonias with connective tissue diseases features: A review , 2016, Respirology.

[54]  D. Lynch,et al.  Longitudinal Follow-up of Fibrosing Interstitial Pneumonia: Relationship Between Physiologic Testing, Computed Tomography Changes, and Survival Rate , 2011, Journal of thoracic imaging.

[55]  M. Roth,et al.  Predictors of lung function decline in scleroderma-related interstitial lung disease based on high-resolution computed tomography: implications for cohort enrichment in systemic sclerosis–associated interstitial lung disease trials , 2015, Arthritis Research & Therapy.

[56]  N. Sverzellati,et al.  Highlights of HRCT imaging in IPF , 2013, Respiratory Research.

[57]  T. E. King,et al.  Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease , 2009, European Respiratory Journal.

[58]  H. Mukae,et al.  High-resolution CT scoring system-based grading scale predicts the clinical outcomes in patients with idiopathic pulmonary fibrosis , 2014, Respiratory Research.

[59]  F. Salaffi,et al.  Computer-Aided Tomographic Analysis of Interstitial Lung Disease (ILD) in Patients with Systemic Sclerosis (SSc). Correlation with Pulmonary Physiologic Tests and Patient-Centred Measures of Perceived Dyspnea and Functional Disability , 2016, PloS one.

[60]  J. Ryu,et al.  Predictors of diagnosis and survival in idiopathic pulmonary fibrosis and connective tissue disease-related usual interstitial pneumonia , 2014, Respiratory Research.

[61]  D. Hansell,et al.  Evaluation of computer-based computer tomography stratification against outcome models in connective tissue disease-related interstitial lung disease: a patient outcome study , 2016, BMC Medicine.

[62]  D. Hansell,et al.  Interobserver agreement for the ATS/ERS/JRS/ALAT criteria for a UIP pattern on CT , 2015, Thorax.

[63]  Gary K Grunwald,et al.  Quantitative CT indexes in idiopathic pulmonary fibrosis: relationship with physiologic impairment. , 2003, Radiology.

[64]  A. Devaraj.  Imaging: how to recognise idiopathic pulmonary fibrosis , 2014, European Respiratory Review.

[65]  M. Puderbach,et al.  MRI of the lung (3/3)—current applications and future perspectives , 2012, Insights into Imaging.

[66]  Takeshi Johkoh,et al.  Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline , 2018, American journal of respiratory and critical care medicine.

[67]  N. Sverzellati,et al.  Visual score and quantitative CT indices in pulmonary fibrosis: Relationship with physiologic impairment , 2007, La radiologia medica.

[68]  Paul J. Friedman,et al.  American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors , 2002, American journal of respiratory and critical care medicine.

[69]  Kyung Soo Lee,et al.  High-resolution CT findings in fibrotic idiopathic interstitial pneumonias with little honeycombing: serial changes and prognostic implications. , 2012, AJR. American journal of roentgenology.

[70]  F. Martinez,et al.  Predictors of idiopathic pulmonary fibrosis in absence of radiologic honeycombing: A cross sectional analysis in ILD patients undergoing lung tissue sampling. , 2016, Respiratory medicine.

[71]  M. Chung,et al.  Prognostic determinants among clinical, thin-section CT, and histopathologic findings for fibrotic idiopathic interstitial pneumonias: tertiary hospital study. , 2008, Radiology.

[72]  D. Hansell,et al.  Interstitial lung disease in systemic sclerosis: a simple staging system. , 2008, American journal of respiratory and critical care medicine.